DOBUTamine Hydrochloride in Dextrose (Hospira, Inc.)


Welcome to the PulseAid listing for the DOBUTamine Hydrochloride in Dextrose drug offered from Hospira, Inc.. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: DOBUTAMINE HYDROCHLORIDE
SUBSTANCE NAME: DOBUTAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-08-12
END MARKETING DATE: 0000-00-00


DOBUTamine Hydrochloride in Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDOBUTamine Hydrochloride in Dextrose from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/100mL)
START MARKETING DATE: 2005-08-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-2346_23b6123e-66d5-4925-a282-e0d533db6159
PRODUCT NDC: 0409-2346
APPLICATION NUMBER: NDA020201

Other DOBUTAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationDobutamine Hydrochloride in Dextrose
General Injectables and Vaccines, Inc.Dobutamine
Hospira, Inc.DOBUTamine Hydrochloride in Dextrose
Physicians Total Care, Inc.Dobutamine